A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Atrial Fibrillation
Related studies linked through entity extraction aliases.
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence
- Status
- COMPLETED
- Phase
- NA
Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
- Status
- UNKNOWN
- Phase
- NA
Inhaled Sevoflurane Compared to Intravenous Sedation Post Coronary Artery Bypass Grafting
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
DISCOVERY: Diagnostic Data and Genetic Polymorphisms in ICD Patients.
- Status
- COMPLETED
- Phase
- NA
Pivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed Drugs
- Status
- TERMINATED
- Phase
- PHASE3
Follow-up Study of the RAI-Treated Hyperthyroid Patients
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety Study on Agilis NxT Introducer in AF Patients
- Status
- COMPLETED
- Phase
- NA
Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE3
Atrial Fibrillation Ablation Device Comparison Study
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients
- Status
- COMPLETED
- Phase
- PHASE4
Treatment of Atrial Fibrillation by Minimal Invasive Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE2
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery
- Status
- TERMINATED
- Phase
- NA
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
- Status
- COMPLETED
- Phase
- PHASE4